Sotorasib User Reviews & Ratings
Brand names: Lumakras
Sotorasib has an average rating of 10.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Non Small Cell Lung Cancer | 1 reviews for Non Small Cell Lung Cancer | 68 medications |
See also:
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Lumakras
Lumakras is used to treat KRAS G12C-mutated non-small cell lung cancer (NSCLC) or colorectal cancer ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
Are you taking this medicine?
Your review helps others make informed decisions.More about sotorasib
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
For Non Small Cell Lung Cancer "I am very fortunate as I have only been taking Lumakras for 12 weeks and have shown positive results already. In my 1st CT scan since starting the drug, my cancer cells have remained the same, some have shrunk in size, and some have disappeared. My prescription is to take 3 pills of 320mg each in the morning."